Vitamin Shoppe Inc trades as part of the consumer cyclical sector and retail apparel and specialty industry. The company CEO is Sharon M. Leite. Vitamin Shoppe Inc is a specialty retailer and contract manufacturer of nutritional products. It offers vitamins, minerals, specialty supplements, herbs, sports nutrition, under brands such as The Vitamin Shoppe, BodyTech, True Athlete, and MyTrition.
Previous Intraday Trading Performance:
The VSI stock showed a previous change of 6.51% with an open at 5.98 and a close of 6.38. It reached an intraday high of 6.41 and a low of 5.87.
The stock has a market cap of $153.1m with 24.0m shares outstanding, of which the float is 13.7m shares. Trading volume reached 891,115 shares compared to its average volume of 500,645 shares. Based on the current average volume and close price, the trading liquidity is bad, highly speculative and an investor may want to avoid this stock.
Historical Trading Performance:
Over the last five trading days, Vitamin Shoppe Inc shares returned 0.95% and in the past 30 trading days it returned -17.78%. Over three months, it changed 39.30%. In one year it has changed 28.89% and within that year its 52-week high was 13.95 and its 52-week low was 4.27. VSI stock is 49.41% above its 52 Week Low.
Our calculations show a 200 day moving average of 7.84 and a 50 day moving average of 6.82. Currently VSI stock is trading -18.62% below its 200 day moving average and may not be a good opportunity to buy as it may continue to trend down.
The last annual fiscal EPS for the company was reported at -0.17 that ended on 31st of December 2018.The TTM EPS is 0.26, which comes to a TTM PE of 24.54.
Base on our calculations, the intrinsic value per share is 33.24, which means it is possibly undervalued and has a margin of safety of 80.81%
Indicators to Watch:
Short-interest is 4,471,841, which is 18.64% of shares outstanding. The short-interest ratio or days-to-cover ratio is 7.71. This stock has a moderate level of short interest, but may still be a buying opportunity depending on other indicators.
The current calculated beta is 1.36
Based on last reported financials, the company’s return on equity is -2.00%, return on assets is -0.87%, profit margin is -0.02%, price-to-sales is 0.22 and price-to-book is 0.80.
All scores are out of six:
5 :Valuation Score
0 :Past Performance Score
4 :Financial Strength Score
0 :Future Growth Score
0 :Dividend Score
2 :Overall Score